 The coronavirus that causes COVID-19 is a completely new virus and we know very little about it. Researchers are taking a wide range of approaches to find an effective and safe treatment. The three main approaches are antivirals, antibodies specific for the virus, and anti-inflammatory drugs, antivirals. These work by preventing the virus from growing inside the body. It'd be great to have an antiviral specific for COVID-19, but it could take years to discover one. In the meantime, researchers are hoping that antivirals against some existing viral diseases might have some benefit in COVID-19. Antibodies attack the virus directly. Antibodies are produced naturally by people who have had the infection and have recovered. When given to patients who are struggling to fight off the infection, antibodies can boost the immune response and stop the virus from growing. In patients with severe COVID-19, what's actually happening is that they're making an over-exaggerated immune response to try to clear the infection. We hope to use anti-inflammatory drugs to modulate that reaction, help clear the infection, but not do any undue damage and harm to the individual.